Check out the latest CMIC Group Webinars! CMIC Group is contract research organization supporting companies in pharmaceutical developments.
As part of the "Developing Your New Medicine in Japan [...]
When utilizing RWD, the selection of the medical information database [...]
10 years ago, CMIC, the leading CRO in Japan, and [...]
The COVID-19 global pandemic took the world by storm, disrupting [...]
Japan and China are the 2nd and 3rd largest pharmaceutical market with [...]
Before COVID-19 vaccine development, mRNA therapeutics has already become a [...]
In recent years, attempts to utilize messenger RNA (mRNA) for [...]
In March 2020, at the height of the COVID-19 outbreak, [...]
The Asia-Pacific (APAC) clinical trials market reached approximately US$3.8 billion [...]
The world rare disease market has grown and it's projected [...]
The global regenerative medicine market was valued at USD 23.8 [...]
In recent years, the large molecule drug development market continues to lead the way with double digit growth, driven by various factors such as increase in elderly population, surge in prevalence of chronic diseases such as cancer and diabetes, and the rise in strategic collaborations and funding in the biopharmaceutical industry. Alongside large molecule drug development, oligonucleotide therapeutics is also emerging as an established and validated class of drugs that can modulate a multitude of genetic targets. Since 2016, five oligonucleotides have been approved to treat a range of diseases.
Since its introduction in the 1980s, the market of orally disintegrating tablet (ODT) has grown annually and ODTs are now available in a variety of therapeutic areas, both over-the-counter (OTC) and by prescription. ODT market is projected to reach US$21B in 2023. In this webinar, CMIC and Aprecia experts talked about advanced ODT technologies and its advantages in drug development.
The webinar was presented by experts in CMIC Group, focusing on tips and insights for early phase oncology drug development in Asia: the market trend, development strategy, regulatory requirements and a case study with step-by-step planning to ensure clinical trial success.
The webinar focused on an overview of the Japanese pharmaceutical market, its unique characteristics, regulatory updates and market entry options. Through a case study, our industry experts provided step-by-step guidance on what to look out for and to how to ensure a successful market entry.
© CMIC HOLDINGS Co., LTD. All rights reserved.
